Metabolomics Market Demonstrates Long-Term Growth Potential At 17.3% CAGR

The metabolomics market is rapidly evolving, driven by technological advancements and increasing applications in healthcare and research. As this sector grows, it is set to transform personalized medicine and clinical diagnostics, offering new insights into disease mechanisms and therapeutic approaches. Here's a detailed overview of its projected growth, key players, emerging trends, and principal market segments.

Market Value Outlook and Growth Drivers in the Metabolomics Market
The metabolomics market is projected to expand significantly over the next decade, reaching a valuation of $9.29 billion by 2030. This impressive growth, with a compound annual growth rate (CAGR) of 17.3%, stems from progress in bioinformatics technologies, growing emphasis on personalized medicine, and rising interest in nutrigenomics applications. Additionally, the market benefits from expanding research into metabolic pathways and the deeper integration of metabolomics into clinical diagnostics. Key trends shaping the market include combining precision medicine with metabolomic profiling, the development of cloud-based data platforms for metabolomics, AI-powered recognition of metabolite patterns, automation in high-throughput workflows, and real-time metabolic monitoring enabled by IoT devices.

The metabolomics market size has grown rapidly in recent years. It will grow from $4.17 billion in 2025 to $4.9 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to growing biomarker discovery research, increasing mass spectrometry adoption, rise in cancer metabolism studies, expanding chromatography system usage, growth in metabolite profiling techniques.

Download a free sample of the metabolomics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Companies Steering Innovation in the Metabolomics Market
Several prominent firms lead the metabolomics industry, including Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, and Biocrates Life Sciences AG, among others. These companies are at the forefront of delivering advanced instruments, software, and services that facilitate comprehensive metabolite analysis and interpretation.

Strategic Acquisition Enhances Bruker Corporation's Portfolio
In June 2025, Bruker Corporation, based in the USA and specializing in scientific instruments and life-science technologies, acquired Biocrates Life Sciences AG, an Austrian company focused on mass spectrometry-based quantitative metabolite and lipid analysis. Though the acquisition amount was undisclosed, this move broadens Bruker's capabilities by integrating metabolomics into its multiomics offerings. The deal adds standardized analysis kits, assays, software, and contract research services to Bruker's portfolio, allowing labs to quantify thousands of metabolites from minimal biological samples with greater precision and efficiency.

View the full metabolomics market report:
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Technological Trends Driving the Metabolomics Market Forward
Leading companies in the metabolomics space are prioritizing the development of Integrated Bioinformatics Platforms aimed at enhancing the analysis of complex metabolomic datasets. These platforms support breakthroughs in personalized medicine, biomarker discovery, and understanding diseases by offering comprehensive software that combines multiple bioinformatics tools and databases in one place. For example, in February 2024, Metabolon, Inc. introduced its bioinformatics platform featuring Biomarker Lenses, which allow users to filter metabolite data related to specific pathways or diseases. This platform also provides powerful statistical tools such as T-tests and ANOVAs, enabling researchers to build, compare models, manage metadata, and visualize data effectively for more targeted insights.

Key Market Segments That Propel Metabolomics Growth
This report organizes the metabolomics market into several important segments to provide a clear picture of its scope and drivers:
1) By Product and Service: This includes metabolomics instruments and bioinformatics tools and services.
2) By Indication: Covers areas like cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and other medical conditions.
3) By Application: Encompasses biomarker discovery, drug development, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and more.

Further breakdowns include:
- Metabolomics Instruments: Chromatography instruments such as gas and liquid chromatography; mass spectrometry instruments like LC-MS and GC-MS; and nuclear magnetic resonance (NMR) instruments.
- Bioinformatics Tools and Services: Software for data analysis, statistics, and modeling; metabolomics databases; consulting services for data interpretation and analytics; and training and support offerings.

This detailed segmentation highlights the diversity and complexity of the metabolomics market, reflecting its expanding influence across research and clinical applications worldwide.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.